FERROKIN BIOSCIENCES INC

Profile

Company Names

FERROKIN BIOSCIENCES INC

Addresses

2729 DEBBIE COURT, SAN CARLOS, CA 94070

Phone Numbers

650-218-5710

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$23,999,997.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-02-10 
$3,000,000.00 
$6,000,000.00 
$3,000,000.00 
Debt 
2
2010-06-03 
$5,999,997.00 
$12,000,000.00 
$6,000,003.00 
Equity 
1
2008-10-09 
$15,000,000.00 
$25,450,000.00 
$10,450,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRYANT 
E. 
FONG 
DIRECTOR
NORA THERAPEUTICS, INC.   |  FERROKIN BIOSCIENCES INC   |  ADMA BIOLOGICS, INC.
DENNIS 
 
HENNER, PH.D. 
DIRECTOR
FERROKIN BIOSCIENCES INC
HUGH 
Y. 
RIENHOFF, JR. 
EXECUTIVE OFFICER, DIRECTOR
FERROKIN BIOSCIENCES INC   |  IMAGO BIOSCIENCES, INC.
HUGH 
Y. 
RIENHOFF, JR., M.D. 
EXECUTIVE OFFICER, DIRECTOR
FERROKIN BIOSCIENCES INC
MARTEN 
 
STEEN 
DIRECTOR
FERROKIN BIOSCIENCES INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  HEALTHCAP VI, L.P.   |  CORTENDO AB   |  VAXIN INC.   |  STRONGBRIDGE BIOPHARMA PLC   |  HEALTHCAP VII, L.P.   |  BIOCLIN THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.   |  ARO BIOTHERAPEUTICS CO   |  MAHZI THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-02-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-10 
2010-06-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-03 
2009-11-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-10-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE